Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Scientific Officer
-
Stock Symbol
-
CRNX on Nasdaq
Stephen F. Betz - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
68.6K |
$3.53M |
$51.50 |
Sep 10, 2024 |
Direct |
|
|
Stock Option (right to buy) |
87K |
|
|
Mar 4, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.